Benitec Biopharma Limited EV/EBITDA

EV/EBITDA of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/EBITDA growth rates and interactive chart. EV/EBITDA is a ratio that compares a company’s Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation & Amortization (EBITDA). The EV/EBITDA ratio is a valuation metric used to compare the relative value of different businesses. A low EV/EBITDA compared to a stock’s historical average or industry can indicate undervaluation.


Highlights and Quick Summary

Current EV/EBITDA of Benitec Biopharma Limited is 0.18 (as of June 30, 2022)
  • EV/EBITDA for the quarter ending June 30, 2022 was 0.18 (a -60.0% decrease compared to previous quarter)
  • Year-over-year quarterly EV/EBITDA decreased by -87.4%
  • Annual EV/EBITDA for 2022 was 0.18 (a -87.4% decrease from previous year)
  • Annual EV/EBITDA for 2021 was 1.45 (a 14.6% increase from previous year)
  • Annual EV/EBITDA for 2021 was 1.27 (a 9.54% increase from previous year)
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/EBITDA of Benitec Biopharma Limited

Most recent EV/EBITDAof BNTC including historical data for past 10 years.

Interactive Chart of EV/EBITDA of Benitec Biopharma Limited

Benitec Biopharma Limited EV/EBITDA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.18 0.46 0.18
2021 0.66 1.45 0.93 1.45
2020 1.27 0.73 1.16 1.47 1.16
2019 2.82 0.0 0.0
2018 0.0
2017 0.0 0.0
2016 0.0 0.0
2015 0.0
2014 0.0
2013 0.0

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology